Aripiprazolo Sandoz 5 mg

Aripiprazolo Sandoz is a generic pharmaceutical product used to treat certain mental/mood disorders. Sandoz, the brand behind this medication, is a global leader in generic and biosimilar medicines. Historically, Sandoz has roots as one of the original Swiss chemical companies that merged to form Novartis. However, in October 2023, Sandoz officially completed its spin-off from Novartis to become a fully independent, standalone public company. The manufacturing of Sandoz products occurs across a vast global network of facilities, primarily focused in Europe (such as Austria, Germany, and Slovenia) to ensure high-quality standards for international distribution.